Lannett (LCI) Will Review FY16 Projects Due to Market Weakness

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Lannett (LCI) Will Review FY16 Projects Due to Market Weakness

Lannett (LCI) Unit and Key Customer in Talks to Reestablish Relationship

March 14, 2016 6:16 AM EDT

Lannett Company, Inc. (NYSE: LCI) announced that its wholly owned subsidiary, Kremers Urban Pharmaceuticals Inc. (KU), and a key customer are in the process of re-establishing business relations.

"We are extremely pleased to have the opportunity to restore business relations with this important customer,"... More